GGrantIndex
Sort

23,748 grants matching melanoma

Activation of Proto-Oncogenes by Chromosomal Translocation

$344,087
Peter D Aplan · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Role and mechanisms of IGF2BP1 in melanoma pathogenesis

$344,050
Vladimir S. Spiegelman · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · CA

Druggable Genetic Lesions in Pediatric Astrocytoma

$344,049
William C Hahn · Dana-Farber Cancer Inst · P01 · FY2015 · CA

Research Project 1 - Targeting the MAPK and PI3K pathways in melanoma PDX

$344,048
Meenhard Herlyn · Wistar Institute · U54 · FY2021 · CA

MECHANOSURVEILLANCE IN BREAST CANCER METASTASIS

$344,025
Ekrem Emrah Er · University Of Illinois At Chicago · R37 · FY2024 · CA

Chemiexcitation: A New Mode of Skin Disease

$344,006
Douglas E Brash · Yale University · R01 · FY2019 · AR

UV damage, repair, and mutagenesis

$344,000
City Of Hope/Beckman Research Institute · R37 · FY2005 · ES

UV damage, repair, and mutagenesis

$344,000
City Of Hope/Beckman Research Institute · R37 · FY2004 · ES

Nuclear Accumulation of D-type Cyclins and Oncogenesis

$343,960
J. Alan Diehl · Case Western Reserve University · R01 · FY2020 · CA

Discovery of small molecule inhibitors for protein N-terminal methyltransferase

$343,925
Rong Huang · Purdue University · U01 · FY2019 · CA

Prevention of skin cancer by phytochemicals via Nrf2 and epigenetics

$343,925
Ah-Ng Tony Kong · Rutgers, The State Univ Of N.J. · R01 · FY2019 · CA

Development of a targeted delivery platform for checkpoint inhibitors

$343,925
Kun Cheng · University Of Missouri Kansas City · R01 · FY2019 · CA

PRECLINICAL STUDY OF PEPTIDE BASED HUMAN TUMOR VACCINES

$343,923
University Of Virginia Charlottesville · R01 · FY2002 · CA

Treating CNS malignancies with 131-I-8H9

$343,914
Sloan-Kettering Institute For Cancer Res · R21 · FY2005 · CA

Replication fork remodeling and genomic stability

$343,830
Alberto Ciccia · Columbia University Health Sciences · R01 · FY2016 · CA

Core 2: ImmunoPhenotyping Core

$343,763
Robert H Pierce · University Of Washington · P01 · FY2020 · CA

Regulation of a DNA damage response network in glioblastoma

$343,754
Andy J Minn · University Of Pennsylvania · R01 · FY2013 · CA

Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression

$343,699
Markus H. Frank · Brigham And Women'S Hospital · R01 · FY2010 · CA

Targeting Abl kinases in BRAF-driven melanomas

$343,683
Rina Plattner · University Of Kentucky · R01 · FY2018 · CA

Tumor Assessment Core

$343,619
Stan Krajewski · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2012 · CA

Bone cancer and skeletal pain

$343,603
University Of Minnesota Twin Cities · R01 · FY2003 · CA

Induction of Therapeutic Immunity in the Tumor Microenvironment

$343,580
Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA

Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance

$343,564
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2024 · CA

Moving TIL Therapy Past the Valley of Death

$343,484
John Wilson · Wilson Wolf Manufacturing Corporation · U44 · FY2011 · CA

Brain Tumor Targeting Using Tumor-Specific Neuroimmunology

$343,438
John H Sampson · Duke University · R01 · FY2014 · NS